Pick the protection that FITS YOUR PATIENTS
Duramune Lyme
®
+ Max 5-CvK
Duramune Lyme
®
+ Max 5-CvK/4L
Duramune Lyme
®
+ Max 5/4L
Duramune Lyme
®
+ LeptoVax
®
4
Duramune
Lyme
®
ULTRA
TM
Duramune
Lyme
®
DURAMUNE LYME
®
.
The first portfolio of Lyme
combination vaccines
Lyme disease is a serious threat to many dogs
•
Proven effectiveness with
fewer injections than single-antigen vaccines
1, 2, 3
•
Provides a broad antibody response to many OSPs
2,4
•
Multiple opportunities to stop Lyme disease before it starts
•
Now includes ULTRA
™
Duramune Lyme
®
References: 1. Levy SA. 2002. "Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection."
Vet Ther. 3(4):420–424. 2. Chu H., Chavez L. et al. 1992. "Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin." J Am Vet Med Assoc. 201(3):403–411 3. Levy
S., Lissman B. et al. 1993. "Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas." J Am Vet Med Assoc. 202(11):1834–1838. 4. Levy S., Millership J. et al. 2010.
"Confirmation of presence of Borrelia burgdorferi outer surface protein C antigen and production of antibodies to Borrelia burgdorferi outer surface protein C in dogs vaccinated with
a whole-cell Borrelia burgdorferi bacterin." Intern J Appl Res Vet Med. 8(3):123–128.
Choose the Lyme protection that's the right fit for your patients and your practice.
The label contains complete use information, including cautions and warnings. Always read,
understand and follow the label and use directions.
Duramune, Duramune Lyme, ULTRA, LeptoVax, Elanco and the diagonal bar are trademarks owned by
or licensed to Eli Lilly and Company, its subsidiaries or affiliates.
© 2017 Eli Lilly and Company, its subsidiaries or affiliates. All rights reserved.
USCACVDC00036
0.5 mL ULTRA
™
Duramune Lyme
®
TRY
ULTRA
URAMUNE
LYME
Now available from